Preview

Rheumatology Science and Practice

Advanced search

PROGRESSION AND OUTCOMES OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDILITIS

https://doi.org/10.14412/1995-4484-2014-520-525

Abstract

Uveitis is a common extraskeletal manifestation of ankylosing spondylitis (AS) occurring in 20–40% of patients. Most
authors underline a favorable prognosis for AS-associated uveitis.
Objective: to study features of clinical picture and progression of AS-associated uveitis and to estimate the occurrence of its complications.

Subjects and methods. Across-sectional study of 140 patients (98 males and 42 females) with AS, who had at least one uveitis attack over the period of disease and was followed up at V.A. Nasonova Research Institute of Rheumatology during 2008–2012. In addition to standard rheumatologic examination all patients were examined by ophthalmologist. Biomicroscopy, ophthalmoscopy, tonometry, computer-assisted perimetry, ultrasonography (B-scanning) of eyes and, if needed, fluorescein angiography and electrophysiological examination of retina were performed. Localization of uveitis, presence of complications affecting vision, total number of uveitis attacks by the moment of examination, mean number of uveitis attacks per year, correlation between the frequency of attacks and complications, presence of other extraskeletal manifestations and peripheral arthritis were assessed. The total number of uveitis attacks was defined from patients' interviews and respective medical documentation. Mean number of uveitis attacks was calculated as ratio of total number of uveitis attacks to the duration of disease for each patient. In the case of more than two attacks per year uveitis progression was considered
refractory.

Results.Mean duration of the disease was 17.7±11.03 years. In 19 patients (14%) AS manifested before and in 121 (86%) – after the age of 16 years. HLA-B27 was revealed in 135 (96%) patients, peripheral arthritis – in 43 (30%), whereas other extraskeletal manifestations – in 46 (32%). Early onset of uveitis in first 10 years of the disease was recorded in 81 (58%) patients, after10 years – in 21 (15%). Uveitis was the first clinical symptom of AS in 37 (26.4%) patients. 33 (24%) patients had more than 10 uveitis attacks during the disease, 17 (12%) – more than two attacks per year, whereas 18 (13%) had chronic uveitis. 118 (84%) had localized iridocyclitis, 12 (8%) – panuveitis, 2 (1%) – localized posterior uveitis. 122 (87%) patients had unilateral uveitis, 18 (13%) – bilateral, whereas 45 (36%) – alternating eye lesions (OD-OS). Uveitis complicated with vision impairment was observed in 41 (29%) patients: synechia in 26 (18%), vitreous degeneration – in 20 (14%), cataract – in 32 (23%), glaucoma – in 13 (9%), maculopathy – in 6 (4%), ribbon-like retinal degeneration – in 6 (4%), partial optic nerve atrophy – in 3 (2%). Authors revealed direct correlation between frequency of uveitis attacks and occurrence of synechia, cataract, glaucoma, vitreous degeneration.

Conclusion. AS-associated uveitis is predominantly characterized by unilateral iridocyclitis (84%) and the onset in the first 10 years of disease (84.4%); 25% of cases were remarkable for frequent relapses: more than two attacks per year and more than 10 during the period of disease. One third of patients demonstrated vision impairments, and its progression correlated with the frequency of uveitis attacks.

About the Authors

A. A. Godzenko
Russian Medical Academy of Postgraduate Education of Ministry of Health of Russian Federation, Moscow, Russia
Russian Federation


A. G. Bochkova
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation


O. A. Rumyantseva
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation


I. Yu. Razumova
Research Institute of Ocular diseases, Moscow, Russia
Russian Federation


V. V. Badokin
Russian Medical Academy of Postgraduate Education of Ministry of Health of Russian Federation, Moscow, Russia
Russian Federation


Sh. F. Erdes
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation


References

1. Кацнельсон ЛА, Танковский ВЭ. Увеиты (клиника, лечение). Москва: 4-й филиал Воениздата; 2003. 286 c. [Katsnel'son LA, Tankovskii VE. Uveity (klinika, lechenie) [Uveita (clinic, treatment)]. Moscow: 4-i filial Voenizdata; 2003. 286 p.]

2. Feltkamp TEW, Ringrose J. Acute anterior uveitis and spondyloarthropathies. Curr Opin Rheumatol. 1998;10(4):314–8. DOI: http://dx.doi.org/10.1097/00002281-199807000-00006.

3. Martin TM, Smith JR, Rosenbaum JT. Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies. Curr Opin Rheumatol. 2002;14(4):337–41. DOI: http://dx.doi.org/10.1097/00002281-200207000-00001.

4. Wright V. A unifying concept of the seronegative polyarthritis. Clin Orthop. 1979;(143):8–14.

5. Brewerton DA, Caffrey M, Nicholls A, et al. Letter: Acute anterior uveitis and HL-A 27. Lancet. 1974;161(7855):464. DOI: http://dx.doi.org/10.1016/S0140–6736(74)92431–3.

6. Taurog JD. The role of HLA-B27 in spondyloarthritis. J Rheumatol. 2010;37(12):2606–16. DOI: 10.3899/jrheum.100889.

7. Rosenbaum J. Why HLA-B27? My Thirty-Year Quest. Invest Ophthalmol Vis Sci. 2011;52(10):7712–5. DOI: 10.1167/iovs.11-8247.

8. Spencer D, Hick H, Dick W. Ankylosing spondylitis – the role of HLA-B27 homozygosity. Tissue Antigens. 1979 Nov;14(5):379–84. DOI: http://dx.doi.org/10.1111/j.1399- 0039.1979.tb00866.x.

9. Moller P, Vinje O, Berg K. HLA antigens, psoriasis and acute anterior uveitis in Bechterew's syndrome (ankylosing spondylitis). Clin Genet. 1982;21(3):215–21. DOI: http://dx.doi.org/10.1111/j.1399-0004.1982.tb00966.x.

10. Van der Linden S, Valkenburg HA, Cats A. Is uveitis associated with ankylosing spondylitis or with HLA-B27? Br J Rheumatol. 1983 Nov;22(4 Suppl 2):146–7.

11. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum. 2007 Oct;56(10):3248–52. DOI: http://dx.doi.org/10.1002/art.22918.

12. Kakkassery V, Mergler S, Pleyer U. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? Observational report on six patients: occurrence of uveitis following etanercept treatment. Curr Eye Res. 2010 Aug;35(8):751–6. DOI: 10.3109/02713683.2010.486520.

13. Kezic JM, Davey MP, Glant TT, Rosenbaum J. IFN-gamma regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondyloarthritis. Arthritis Rheum. 2012;64(3):762–71. DOI: 10.1002/art.33404.

14. Zou J, Appel H, Rudwaleit M, et al. Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis. Ann Rheum Dis. 2005;64(5):722–9. DOI: http://dx.doi.org/10.1136/ard.2004.024455.

15. Moll J. Spondarthritides. In: Rheumatology in clinical practice. Oxford; 1987.

16. Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol. 1989;16(6):792–6.

17. Годзенко АА, Разумова ИЮ, Бочкова АГ. Клиническая оценка увеита и ее значение в диагностике спондилоартритов. Научно-практическая ревматология. 2011;(6):38–42. [Godzenko AA, Razumova IYu, Bochkova AG. Clinical uveitis evaluation and its value in the diagnosis of spondyloarthritis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2011;(6):38–42. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2011-519.

18. Dodds EM, Lowder CY, Meister DM. Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics. Ocul Immunol Inflamm. 1999;7(2);85–92.

19. Rodriguez A, Akova YA, Pedroza-Seres M, Foster C. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994;101(7):1267–74. DOI: http://dx.doi.org/10.1016/S0161-6420(94)31179-1.

20. Yang PZ, Wang H, Zhang Z, et al. Clinical diagnosis and treatment of uveitis associated with ankylosing spondylitis. Zhonghua Yan Ke Za Zhi. 2005 Jun;41(6):515–8.

21. Gouveia E, Elmann D, Morales M. Ankylosing spondylitis and uveitis: overview. Rev Bras Reumatol. 2012 Oct;52(5):742–56.

22. Van der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal to modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8. DOI: http://dx.doi.org/10.1002/art.1780270401.

23. Gehlen M, Regis K, Skare T. Demographic, clinical, laboratory and treatment characteristics of spondyloarthritis patients with and without acute anterior uveitis. Sao Paulo Med J. 2012;130(3):141–4. DOI: http://dx.doi.org/10.1590/S1516-31802012000300002.

24. Годзенко АА, Бочкова АГ, Румянцева ОА и др. Взаимосвязь между поражением сердца и другими клиническими проявлениями анкилозирующего спондилита. Научно- практическая ревматология. 2010;(5):32–6. [Godzenko AA, Bochkova AG, Rumyantseva OA, et al. Association between cardiac lesion and other clinical manifestationsof ankylosing spondylitis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2010;(5):32–6. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2010-728.

25. Катаргина ЛА. Постувеальная глаукома у детей и подростков. Глаукома. 2003;(4):23–5. [Katargina LA. Postuvealny glaucoma at children and teenagers. Glaukoma. 2003;(4):23–5. (In Russ.)]


Review

For citations:


Godzenko A.A., Bochkova A.G., Rumyantseva O.A., Razumova I.Yu., Badokin V.V., Erdes Sh.F. PROGRESSION AND OUTCOMES OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDILITIS. Rheumatology Science and Practice. 2014;52(5):520-525. (In Russ.) https://doi.org/10.14412/1995-4484-2014-520-525

Views: 1526


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)